Valeant Pharma (VRX) call put ratio 2.66 calls to 1 put with focus on May weekly 19 and 19.50 calls into Q1 and outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Valeant Pharma (VRX) call put ratio 2.66 calls to 1 put with focus on May weekly 19 and 19.50 calls into Q1 and outlook

Valeant Pharma (VRX) Reports Q1 Revenues Above Estimates; Boosts FY18 Revenue & EBITDA Outlook

May 8, 2018 7:05 AM EDT

Valeant Pharma (NYSE: VRX) reported Q1 EPS of ($7.68), versus $0.60 reported last year. Revenue for the quarter came in at $2 billion versus the consensus estimate of $1.95 billion.

Outperformed Expectations in the First Quarter of 2018Revenues of $1.995 BillionGAAP Net Loss of $2.693 BillionGAAP Cash Flow from... More